Dr. Boden-Albala describes why involvement of diverse populations is critical to clinical trials, why inclusion remains suboptimal, and what we can do about it in this piece in Neuron, “Confronting legacies of underrepresentation in clinical trials: The case for greater diversity in research.”
Check out NIMICT’s latest publication in the Journal of Racial and Ethnic Health Disparities, Barriers and Strategies for Recruitment of Racial and Ethnic Minorities: Perspectives from Neurological Clinical Research Coordinators.
Dr. Bernadette Boden-Albala outlines critical features for stroke prevention studies in her article, Education Strategies for Stroke Prevention.
2016: The Year of Diversity in Clinical Trials
Visit NIMICT’s YouTube Channel Below is Researchers Discuss: How to Effectively Budget for Your Clinical Trial
NIMICT presented their survey results at the International Stroke Conference in San Diego, California February 12-14. Add visiting NIMICT’s poster to your itinerary.